Dr. Kathryn M. Anastos is a founding Multiple Principal Investigator for Central Africa IeDEA and led the project from 2011 to early 2025. In her IeDEA leadership role, she oversaw the development of data collection processes in low-resource settings, the scientific analysis of collected data to answer critical research questions, and capacity-building projects to improve the independent research infrastructure in IeDEA participating countries. She also led the Rwanda/Einstein Research Consortium in HIV/HPV—training professional researchers in the US and in Rwanda. Her areas of research interest include survival and disease progression among individuals with HIV infection, the role of sex and race in biologically determined antiretroviral (ART) responses, HIV-related malignancies with particular focus on cervical cancer, the impact of HIV-related immune dysfunction or treatment on other medical conditions of aging, and translational research investigations involving biologic materials from clinically well-characterized participants. She has published over 280 articles on HIV.
Dr. Anastos has a MD from the University of California, San Diego School of Medicine. She is a Professor in Medicine, Epidemiology & Population Health, and Obstetrics & Gynecology and Women’s Health at Albert Einstein College of Medicine. She is the Director of Research & Capacity Building for the Women’s Equity in Access to Care and Treatment and Principal Investigator for the Women’s Interagency HIV Study and Rwanda Women’s Interassociation Study & Assessment at Montefiore Medical Center.